1. Cai, Yujie, Ji, Yao, Liu, Yingxuan, Wang, Yan, Cui, Lili. 2024. Microglial circ-UBE2K exacerbates depression by regulating parental gene UBE2K via targeting HNRNPU. In Theranostics, 14, 4058-4075. doi:10.7150/thno.96890. https://pubmed.ncbi.nlm.nih.gov/38994030/
2. Wang, Xiong, Xie, Jiazhao, Tan, Lu, Li, Xiaoguang, Cheng, Liming. 2023. N6-methyladenosine-modified circRIMS2 mediates synaptic and memory impairments by activating GluN2B ubiquitination in Alzheimer's disease. In Translational neurodegeneration, 12, 53. doi:10.1186/s40035-023-00386-6. https://pubmed.ncbi.nlm.nih.gov/38012808/
3. Ouyang, Guangxiong, Fu, Wen, Guo, Jinhui, Huang, Dongsheng, Zhang, Yaping. 2023. Hypoxia-induced UBE2K promotes the malignant progression of HCC. In Pathology, research and practice, 245, 154422. doi:10.1016/j.prp.2023.154422. https://pubmed.ncbi.nlm.nih.gov/37003132/
4. Lei, Xiangxiang, Hu, Xiaoge, Lu, Qiliang, Huang, Dongsheng, Xu, Qiuran. 2022. UBE2K promotes the malignant progression of hepatocellular carcinoma by regulating c-Myc. In Biochemical and biophysical research communications, 638, 210-218. doi:10.1016/j.bbrc.2022.11.046. https://pubmed.ncbi.nlm.nih.gov/36481361/
5. Fu, Wen, Lei, Xiangxiang, Lu, Qiliang, Tong, Xiangmin, Hu, Xiaoge. 2023. UBE2K regulated by IGF2BP3 promotes cell proliferation and stemness in pancreatic ductal adenocarcinoma. In International journal of oncology, 62, . doi:10.3892/ijo.2023.5500. https://pubmed.ncbi.nlm.nih.gov/36896783/
6. Fatima, Azra, Irmak, Dilber, Noormohammadi, Alireza, Rada-Iglesias, Alvaro, Vilchez, David. 2020. The ubiquitin-conjugating enzyme UBE2K determines neurogenic potential through histone H3 in human embryonic stem cells. In Communications biology, 3, 262. doi:10.1038/s42003-020-0984-3. https://pubmed.ncbi.nlm.nih.gov/32451438/
7. Xin, Zhen, Holgersson, Kristian, Zhu, Pengcheng, Szekely, Laszlo, Wu, Tao. . Silencing UBE2K inhibits the growth of glioma cells by inducing the autophagy-related apoptosis. In Journal of biochemical and molecular toxicology, 38, e23758. doi:10.1002/jbt.23758. https://pubmed.ncbi.nlm.nih.gov/38963134/
8. Wang, Qingqing, Dong, Zhigao, Su, Junnan, Ma, Lili, Chen, Xuyan. 2021. Ixazomib inhibits myeloma cell proliferation by targeting UBE2K. In Biochemical and biophysical research communications, 549, 1-7. doi:10.1016/j.bbrc.2021.02.048. https://pubmed.ncbi.nlm.nih.gov/33647537/
9. Guo, Jinhui, Zhao, Jie. . N6-Methyladenosine Modification and Prognostic Analysis of UBE2K in Hepatocellular Carcinoma: A Potential Target. In Critical reviews in eukaryotic gene expression, 33, 41-55. doi:10.1615/CritRevEukaryotGeneExpr.2023048801. https://pubmed.ncbi.nlm.nih.gov/37606163/